Sustainability to drive Pregis product development in Europe

Published: 10-Dec-2010
Packaging Finance

To focus on environmentally friendly products in 2011

The new president of Pregis’ European protective packaging business says the firm will focus on sustainable products in new product developments for 2011.

Kevin Baudhuin has been president of Pregis’ North American protective packaging business since 2007.

He has now been promoted to president of global protective packaging where he will lead Pregis Protective Packaging Europe.

Baudhuin said the firm aimed to create a broad environmentally friendly product portfolio suitable for a number of markets, including medical and pharmaceutical products.

The company already offers its Superlite poly Mailer and EP-Flex Renew biodegradable film products.

‘We recognise that any sustainable solution must still meet other key requirements such as high performance and cost-effectiveness and we will therefore ensure that our products continue to satisfy all these criteria,’ said Baudhuin.

He added that the firm’s growth strategy would focus on three main areas of sustainability, innovation and customer partnerships.

See more

You may also like

Manufacturing

Pregis announces film converting, equipment assembly facilities

Read more
The company’s converting equipment has been self-manufactured and was designed to ensure it’s capable of meeting performance goals including output, sealing and puncture resistance

Trending Articles

  1. Genmab to acquire Merus in $8bn deal to expand late-stage pipeline The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027
  2. Sharp appoints Samantha Wilson Jones as General Counsel Sharp Services has appointed Samantha Wilson Jones as General Counsel and Corporate Secretary of Sharp
  3. Nanologica secures first insulin purification order in China The SEK 2m deal will see the company’s silica-based NLAB Saga evaluated at production scale by a Chinese insulin manufacturer
  4. Symbiosis expands sterile manufacturing capacity with fill/finish line qualification Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    From box to bedside: unlocking patient-centric care with connected packaging Pharmaceutical packaging is playing an increasing role in patient–centric care. The integration of smart 2D codes and connected digital platforms can provide a direct link between pharma manufacturers, healthcare providers and patients

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Manufacturing

Pregis announces film converting, equipment assembly facilities

The company’s converting equipment has been self-manufactured and was designed to ensure it’s capable of meeting performance goals including output, sealing and puncture resistance
Packaging

Pregis launches high speed bagger with predictive maintenance

The unit features an intuitive user interface and thermal printing technology, which prints bar codes, graphics and alphanumeric fonts directly onto the package
Packaging

Pregis adds bagging systems to protective packaging portfolio

The protective packaging company has acquired Sharp Packaging Systems and its flexible bagging systems capability
Packaging

Pregis acquires UK-based protective packaging company Easypack

Will expand its North American portfolio to include paper void fill, cushioning and block/brace solutions
Distribution

Cold Chain Technologies launches “Smart Chain, Clear Gain” campaign to elevate digitalisation in pharma logistics

Leading temperature-controlled solution provider, Cold Chain Technologies (CCT), has unveiled its new campaign, Smart Chain, Clear Gain, aimed to redefine how pharmaceutical companies approach compliance, efficiency and value in cold chain logistics
Finance

SeaBeLife raises €2 million to advance dual-target cell death therapies

The funding will help fast-track clinical trials for treatments addressing dry age-related macular degeneration and severe acute hepatitis, supporting the company’s innovative approach to blocking two major regulated cell death pathways
Research & Development

Daiichi Sankyo launches third global research institute in San Diego

The company expands its international research footprint with a new San Diego institute, strengthening collaborations in one of the world’s leading life-science hubs and advancing its global drug discovery strategy
Subscribe now